Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-negative breast cancer.
Demir N, Gökmen İ, Garbioğlu DB, Taştekin E, Işık E, Özcan E, Erdoğan B, Topaloğlu S, Köylü B, Kıkılı Cİ, Kemik F, Çiçin İ, Selçukbiricik F, Hacıoğlu MB
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.